Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial

Fibroblast growth factor 23 (FGF23) is an independent risk factor for cardiovascular mortality in chronic kidney disease. Omega-3 (n-3) fatty acid consumption has been inversely associated with FGF23 levels and with cardiovascular risk. We examined the effect of marine n-3 fatty acids eicosapentaeno...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients
Main Authors: de Borst, Martin H., Baia, Leandro C., Hoogeveen, Ellen K., Giltay, Erik J., Navis, Gerjan, Bakker, Stephan J. L., Geleijnse, Johanna M., Kromhout, Daan, Soedamah-Muthu, Sabita S.
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5707705/
https://ncbi.nlm.nih.gov/pubmed/29137111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu9111233
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items